Activation of NF-κB by the full-length nucleocapsid protein of the SARS coronavirus

Qing Jiao Liao, Lin Bai Ye, Khalid A. Timani, Ying Chun Zeng, Ying Long She, Li Ye, Zheng Hui Wu

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) is the major causative agent for the worldwide outbreak of SARS in 2003. The mechanism by which SARS-CoV causes atypical pneumonia remains unclear. The nuclear factor kappa B (NF-κB) is a key transcription factor that activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-κB plays an important role in the pathogenesis of lung diseases. In this study, we investigated the possible regulatory interaction between the SARS-CoV nucleocapsid (N) protein and NF-κB by luciferase activity assay. Our results showed that the SARS-CoV N protein can significantly activate NF-κB only in Vero E6 cells, which are susceptible to SARS-CoV infection, but not in Vero or HeLa cells. This suggests that NF-κB activation is cell-specific. Furthermore, NF-κB activation in Vero E6 cells expressing the N protein is dose-dependent. Further experiments showed that there is more than one function domain in the N protein responsible for NF-κB activation. Our data indicated the possible role of the N protein in the pathogenesis of SARS.

Original languageEnglish
Pages (from-to)607-612
Number of pages6
JournalActa Biochimica et Biophysica Sinica
Volume37
Issue number9
DOIs
StatePublished - 1 Sep 2005

Fingerprint

SARS Virus
Nucleocapsid Proteins
NF-kappa B
Severe Acute Respiratory Syndrome
Chemical activation
Vero Cells
Coronavirus
Coronavirus Infections
Proteins
Nucleocapsid
Pulmonary diseases
Luciferases
HeLa Cells
Cellular Immunity
Lung Diseases
Disease Outbreaks
Assays
Pneumonia
Transcription Factors
Genes

Keywords

  • NF-κB
  • Nucleocapsid protein
  • Severe acute respiratory syndrome coronavirus (SARS-CoV)

Cite this

Liao, Qing Jiao ; Ye, Lin Bai ; Timani, Khalid A. ; Zeng, Ying Chun ; She, Ying Long ; Ye, Li ; Wu, Zheng Hui. / Activation of NF-κB by the full-length nucleocapsid protein of the SARS coronavirus. In: Acta Biochimica et Biophysica Sinica. 2005 ; Vol. 37, No. 9. pp. 607-612.
@article{58c58081a8a74c8bbdac0eab93fa7f0e,
title = "Activation of NF-κB by the full-length nucleocapsid protein of the SARS coronavirus",
abstract = "The severe acute respiratory syndrome coronavirus (SARS-CoV) is the major causative agent for the worldwide outbreak of SARS in 2003. The mechanism by which SARS-CoV causes atypical pneumonia remains unclear. The nuclear factor kappa B (NF-κB) is a key transcription factor that activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-κB plays an important role in the pathogenesis of lung diseases. In this study, we investigated the possible regulatory interaction between the SARS-CoV nucleocapsid (N) protein and NF-κB by luciferase activity assay. Our results showed that the SARS-CoV N protein can significantly activate NF-κB only in Vero E6 cells, which are susceptible to SARS-CoV infection, but not in Vero or HeLa cells. This suggests that NF-κB activation is cell-specific. Furthermore, NF-κB activation in Vero E6 cells expressing the N protein is dose-dependent. Further experiments showed that there is more than one function domain in the N protein responsible for NF-κB activation. Our data indicated the possible role of the N protein in the pathogenesis of SARS.",
keywords = "NF-κB, Nucleocapsid protein, Severe acute respiratory syndrome coronavirus (SARS-CoV)",
author = "Liao, {Qing Jiao} and Ye, {Lin Bai} and Timani, {Khalid A.} and Zeng, {Ying Chun} and She, {Ying Long} and Li Ye and Wu, {Zheng Hui}",
year = "2005",
month = "9",
day = "1",
doi = "10.1111/j.1745-7270.2005.00082.x",
language = "English",
volume = "37",
pages = "607--612",
journal = "Acta Biochimica et Biophysica Sinica",
issn = "1672-9145",
publisher = "Oxford University Press",
number = "9",

}

Activation of NF-κB by the full-length nucleocapsid protein of the SARS coronavirus. / Liao, Qing Jiao; Ye, Lin Bai; Timani, Khalid A.; Zeng, Ying Chun; She, Ying Long; Ye, Li; Wu, Zheng Hui.

In: Acta Biochimica et Biophysica Sinica, Vol. 37, No. 9, 01.09.2005, p. 607-612.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Activation of NF-κB by the full-length nucleocapsid protein of the SARS coronavirus

AU - Liao, Qing Jiao

AU - Ye, Lin Bai

AU - Timani, Khalid A.

AU - Zeng, Ying Chun

AU - She, Ying Long

AU - Ye, Li

AU - Wu, Zheng Hui

PY - 2005/9/1

Y1 - 2005/9/1

N2 - The severe acute respiratory syndrome coronavirus (SARS-CoV) is the major causative agent for the worldwide outbreak of SARS in 2003. The mechanism by which SARS-CoV causes atypical pneumonia remains unclear. The nuclear factor kappa B (NF-κB) is a key transcription factor that activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-κB plays an important role in the pathogenesis of lung diseases. In this study, we investigated the possible regulatory interaction between the SARS-CoV nucleocapsid (N) protein and NF-κB by luciferase activity assay. Our results showed that the SARS-CoV N protein can significantly activate NF-κB only in Vero E6 cells, which are susceptible to SARS-CoV infection, but not in Vero or HeLa cells. This suggests that NF-κB activation is cell-specific. Furthermore, NF-κB activation in Vero E6 cells expressing the N protein is dose-dependent. Further experiments showed that there is more than one function domain in the N protein responsible for NF-κB activation. Our data indicated the possible role of the N protein in the pathogenesis of SARS.

AB - The severe acute respiratory syndrome coronavirus (SARS-CoV) is the major causative agent for the worldwide outbreak of SARS in 2003. The mechanism by which SARS-CoV causes atypical pneumonia remains unclear. The nuclear factor kappa B (NF-κB) is a key transcription factor that activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-κB plays an important role in the pathogenesis of lung diseases. In this study, we investigated the possible regulatory interaction between the SARS-CoV nucleocapsid (N) protein and NF-κB by luciferase activity assay. Our results showed that the SARS-CoV N protein can significantly activate NF-κB only in Vero E6 cells, which are susceptible to SARS-CoV infection, but not in Vero or HeLa cells. This suggests that NF-κB activation is cell-specific. Furthermore, NF-κB activation in Vero E6 cells expressing the N protein is dose-dependent. Further experiments showed that there is more than one function domain in the N protein responsible for NF-κB activation. Our data indicated the possible role of the N protein in the pathogenesis of SARS.

KW - NF-κB

KW - Nucleocapsid protein

KW - Severe acute respiratory syndrome coronavirus (SARS-CoV)

UR - http://www.scopus.com/inward/record.url?scp=26944473682&partnerID=8YFLogxK

U2 - 10.1111/j.1745-7270.2005.00082.x

DO - 10.1111/j.1745-7270.2005.00082.x

M3 - Article

VL - 37

SP - 607

EP - 612

JO - Acta Biochimica et Biophysica Sinica

JF - Acta Biochimica et Biophysica Sinica

SN - 1672-9145

IS - 9

ER -